Testosterone for Menopause: What It Fixes, What It Won't

Does testosterone actually drop at menopause?

Not at menopause itself. In a seven-year study that followed 172 women through their final period, average testosterone did not change at all across the transition. What falls is estrogen. Testosterone drifts down slowly with age instead, and a separate study of 1,423 women found that decline steepest in the early reproductive years. A completely different curve.

That single fact reframes the whole conversation. The pitch you hear in clinics — "menopause crashes your testosterone, we put it back" — describes estrogen, not testosterone. Your ovaries and adrenal glands keep making androgens after your periods stop.

So if you reached menopause naturally and feel flattened at 51, low testosterone is an unlikely explanation on the numbers alone. That doesn't mean nothing is wrong. It means the cause is probably somewhere else, and our article on menopause fatigue walks through the more likely suspects.

Is testosterone approved for women in the US?

No. As of September 2026 there is still no FDA-approved testosterone product for women in the United States, for any indication. Approved women's formulations exist elsewhere, including Australia. American women get male products at a fraction of the dose, or creams and pellets mixed by a compounding pharmacy.

This matters more than it sounds. When a drug is approved, someone has verified the dose in the tube, run the trials, and written a label listing what can go wrong. None of that exists for the testosterone an American woman is handed, no matter how confident the clinic sounds.

What did the FDA say in September 2026?

On September 17, 2026, the FDA held a public workshop on testosterone use in menopausal women. The stated purpose was to examine the current evidence and the critical knowledge gaps, to inform future research and drug development. Regulators asked manufacturers for studies. Nothing was approved that day.

It was, genuinely, a step. An FDA official said the agency stood ready to review applications, and speakers pushed for a product formulated and dosed for women rather than a shaved-down male gel. That is a real change in tone after two decades without an approval.

But a workshop is not an approval, and the experts in the room were careful about why. Evidence supports one use; long-term safety data, especially on the heart and the breast, still don't exist. Read the coverage carefully and the headline is "we need better studies," not "testosterone is cleared."

What does testosterone actually treat in menopause?

One thing, with real evidence behind it: hypoactive sexual desire disorder after menopause. That means desire has dropped low enough to distress you, and eleven medical societies agreed in 2019 that this is the only evidence-based reason to prescribe testosterone to a woman. Everything else is extrapolation.

And if you still have periods? The eleven societies were explicit about that too: there are insufficient data to make any recommendation about testosterone in premenopausal women. The desire evidence comes from women already past menopause.

The effect is real but moderate. In the largest pooled analysis, testosterone improved desire, arousal, orgasm, pleasure and sexual self-image, and reduced sexual distress, in postmenopausal women compared with placebo or with estrogen alone. Those are meaningful outcomes if low desire is what's bothering you.

Notice what's in that second sentence. The same analysis that confirmed the sexual benefit found nothing for muscle, bone or thinking — the same trials, the same researchers, the same paper.

The authors add one caution: few women contributed data on those outcomes. So "no effect found" is not "proven useless". It means nobody has yet run a trial big enough to settle it.

Does testosterone help you sleep?

There is no good evidence that it does. Sleep was not a primary outcome in the trials that got pooled, and the consensus statement does not list sleep among the things testosterone treats. If your nights are broken by night sweats, the hormone with evidence is estrogen, not testosterone.

I want to be fair to the biology here, because there is a plausible story. Sex hormones do influence sleep architecture, and women who sleep badly often have worse everything. But "plausible" and "tested" are different words, and on this one the tests haven't been run.

If sleep is your actual problem, the treatments with evidence behind them are the boring ones. Estrogen therapy when hot flashes are waking you, oral micronized progesterone at bedtime, and CBT-I when your body sleeps fine but your brain won't stop. None of them is testosterone.

Will it fix the fatigue, the mood, or the brain fog?

This is where the marketing runs furthest ahead of the data. Fatigue itself was rarely measured as its own outcome. The closest the global consensus got was general wellbeing and depressed mood, and it found no effect on either, with too little evidence to judge cognition.

Bone density and muscle strength showed nothing either, on the same thin data. So the honest summary is not "testosterone fails at these things" — it is that almost nobody has properly tested them.

That list is almost exactly the list of things testosterone is being prescribed for. Fatigue, low mood, fog, strength, motivation — the symptoms that make a woman in her fifties feel like a stranger to herself. It is the most sympathetic possible reason to try something, and the least supported.

Which leaves the obvious question: then what is it? The usual answers are unglamorous and treatable — an underactive thyroid, low iron, undiagnosed sleep apnea, depression, or simply months of broken sleep. Those are worth ruling out with a blood test and an honest conversation before any hormone enters the picture.

Can a blood test tell you if your testosterone is low?

Not in the way clinics imply. The consensus is blunt: no cut-off blood level of any androgen separates women with sexual problems from women without them. There is no validated diagnosis of female testosterone deficiency. Blood levels are measured for a different reason, which is safety.

There's a technical problem underneath the clinical one. The consensus calls direct assays "highly unreliable in the female range" — they were built for male-range testosterone. The method that does work at these concentrations is mass spectrometry, written on the form as LC-MS/MS. It is worth asking for by name if blood is being drawn at all.

If a clinic hands you a result and says "there's your answer," that's the moment to slow down. The diagnosis of low desire is made by talking to you about your symptoms and your distress, using clinical criteria — not by a lab value.

How is testosterone prescribed to women here?

Usually by taking a gel approved for men and using a small fraction of it, because a woman's normal level is a tenth to a twentieth of a man's, depending on the measure. The consensus calls that reasonable when nothing else is available, as long as your blood level stays inside the normal premenopausal range.

The other route is compounding: a pharmacy mixes a cream or troche to a prescriber's formula. The consensus doesn't recommend compounded testosterone for low desire unless no authorized product can be obtained, for the same reason it applies to compounded bioidentical hormones generally — nobody has verified what's in it.

Both routes share one hazard: dividing a male dose by eye. Ten-fold is a big gap to estimate with a pump or a packet, and overshooting is how women end up with side effects that don't fully reverse.

Why are pellets and injections singled out?

Because they overshoot. The consensus recommends against any preparation that pushes testosterone above the normal female range, and names pellets and injections specifically. A pellet sits under your skin releasing hormone for months, and if the level climbs too high it only comes out with a second procedure to dig it back out.

Pellets also feature prominently in the marketing of cash-pay hormone clinics, where they are presented as the convenient choice: one appointment, months of coverage. That convenience is real. It is also the same property as being hard to undo.

What are the side effects of testosterone for women?

In the pooled trials the reliable ones were acne and extra hair growth, both more common on testosterone than placebo, plus a small weight gain. No serious adverse events were recorded. Taken by mouth it worsened cholesterol; applied to the skin it did not, which is why creams and gels are preferred.

• Acne and unwanted hair growth: the two side effects that showed up consistently across trials
• Oral routes and cholesterol: swallowed testosterone raised LDL and lowered HDL; transdermal did not
• Skin-to-skin transfer: testosterone gels rub off onto other people. The male products carry a boxed warning about exactly this — cover the area, wash your hands, and keep small children off that patch of skin
• Supraphysiologic levels: at physiological doses the consensus found no voice change, hair loss or clitoral enlargement — which is precisely why it recommends against preparations that push you above the normal female range
• Long-term safety: the trials ran for months, not years — breast and cardiovascular outcomes over a decade remain genuinely unknown

That last bullet is the one regulators keep returning to, and it's the honest reason a product still hasn't been approved. It isn't that testosterone was proven dangerous. It's that nobody has run a trial long enough to say it's safe.

How long before you know if it's working?

Six months is the line the consensus draws. Blood is checked before you start, again three to six weeks in, then every six months, to confirm you are not drifting above the female range. If you have felt no benefit by six months, the recommendation is to stop.

Write that stopping rule down before you begin. It's the single most useful thing in the whole guideline, because a treatment with no measurable target and a real cost per month can otherwise continue indefinitely on hope.

Why are prescriptions rising if the evidence hasn't moved?

Because demand has moved. An analysis by the health data firm Truveta, reported by Reuters, found the rate of US women receiving a testosterone prescription rose 146% between January 2023 and July 2026 — nearly tripling — while the underlying evidence base stayed essentially where it was in 2019.

None of that makes the women asking for it wrong. A generation of us was undertreated for menopause, told to cope, and is now understandably impatient. The risk is that impatience gets pointed at the one hormone with the thinnest safety file.

What should you ask before starting testosterone?

Four questions do most of the work. What symptom are we treating, and is it the one with evidence? What product and dose, and how will we keep me in the female range? How will we check my level? And at what point do we agree to call it off?

• "Is this for low desire, or are we treating fatigue? What does the evidence say for that symptom?"
• "What exactly am I being given — an off-label male product, or a compounded cream?"
• "When will you check my blood level, and what number would make you lower the dose?"
• "If I feel no different in six months, will you agree to stop?"

A clinician who welcomes those questions is a good sign. One who answers with a saliva panel and a pellet appointment is telling you something too. If it turns out sleep is the real problem, two weeks of tracking will do more for that appointment than any hormone test.

Where to go from here

If you came here because you're exhausted rather than because desire has gone, start with why menopause makes you tired all day and awake all night — it covers the causes that are actually treatable. For the hormone question in general, our honest look at HRT for menopause insomnia is the place to start.

If the words "bioidentical" or "compounded" came up in the same conversation as testosterone, our guide to FDA-approved versus compounded hormones untangles them. And for how everything fits together, start at the complete perimenopause and menopause sleep guide.

Frequently asked questions